"Aspartic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
| Descriptor ID |
D001224
|
| MeSH Number(s) |
D12.125.067.500 D12.125.119.170 D12.125.427.040
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aspartic Acid".
Below are MeSH descriptors whose meaning is more specific than "Aspartic Acid".
This graph shows the total number of publications written about "Aspartic Acid" by people in this website by year, and whether "Aspartic Acid" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 6 | 18 | 24 |
| 1996 | 6 | 19 | 25 |
| 1997 | 12 | 16 | 28 |
| 1998 | 5 | 13 | 18 |
| 1999 | 6 | 15 | 21 |
| 2000 | 3 | 13 | 16 |
| 2001 | 9 | 18 | 27 |
| 2002 | 15 | 11 | 26 |
| 2003 | 18 | 4 | 22 |
| 2004 | 18 | 10 | 28 |
| 2005 | 8 | 17 | 25 |
| 2006 | 5 | 17 | 22 |
| 2007 | 4 | 13 | 17 |
| 2008 | 3 | 14 | 17 |
| 2009 | 4 | 10 | 14 |
| 2010 | 4 | 11 | 15 |
| 2011 | 6 | 11 | 17 |
| 2012 | 3 | 12 | 15 |
| 2013 | 7 | 10 | 17 |
| 2014 | 4 | 12 | 16 |
| 2015 | 5 | 6 | 11 |
| 2016 | 3 | 12 | 15 |
| 2017 | 3 | 5 | 8 |
| 2018 | 2 | 6 | 8 |
| 2019 | 8 | 4 | 12 |
| 2020 | 3 | 3 | 6 |
| 2021 | 2 | 4 | 6 |
| 2022 | 3 | 6 | 9 |
| 2023 | 0 | 6 | 6 |
| 2024 | 2 | 4 | 6 |
Below are the most recent publications written about "Aspartic Acid" by people in Profiles.
-
Maternal prenatal immune activation associated with brain tissue microstructure and metabolite concentrations in newborn infants. Brain Behav Immun. 2024 Nov; 122:279-286.
-
Altered brain metabolites in male nonhuman primate offspring exposed to maternal immune activation. Brain Behav Immun. 2024 Oct; 121:280-290.
-
Impact of lifetime stressor exposure on neuroenergetics in schizophrenia spectrum disorders. Schizophr Res. 2024 07; 269:58-63.
-
Strain-release alkylation of Asp12 enables mutant selective targeting of K-Ras-G12D. Nat Chem Biol. 2024 Sep; 20(9):1114-1122.
-
Astroglial conditional Slc13a3 knockout is therapeutic in murine Canavan leukodystrophy. Ann Clin Transl Neurol. 2024 Apr; 11(4):1059-1062.
-
Direct measurement of dynamic attractant gradients reveals breakdown of the Patlak-Keller-Segel chemotaxis model. Proc Natl Acad Sci U S A. 2024 Jan 16; 121(3):e2309251121.
-
Hyperpolarized [1-13 C] pyruvate MRSI to detect metabolic changes in liver in a methionine and choline-deficient diet rat model of fatty liver disease. Magn Reson Med. 2024 Apr; 91(4):1625-1636.
-
Real-time resolution studies of the regulation of pyruvate-dependent lactate metabolism by hexokinases in single cells. PLoS One. 2023; 18(11):e0286660.
-
Pathological Bergmann glia alterations and disrupted calcium dynamics in ataxic Canavan disease mice. Glia. 2023 12; 71(12):2832-2849.
-
Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status. Neuroimage Clin. 2023; 39:103461.